Cargando…
Trial Watch: Chemotherapy with immunogenic cell death inducers
Accumulating evidence suggests that the clinical efficacy of selected anticancer drugs, including conventional chemotherapeutics as well as targeted anticancer agents, originates (at least in part) from their ability to elicit a novel or reinstate a pre-existing tumor-specific immune response. One o...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008470/ https://www.ncbi.nlm.nih.gov/pubmed/24800173 http://dx.doi.org/10.4161/onci.27878 |
Search Result 1
Enlace del recurso
Enlace del recurso
por Vacchelli, Erika, Senovilla, Laura, Eggermont, Alexander, Fridman, Wolf Hervé, Galon, Jérôme, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Publicado 2013
Enlace del recurso
Publicado 2013
Enlace del recurso
Enlace del recurso
Online
Artículo
Texto
Search Result 2